Sebaceous Gland Carcinoma: Influence of Age at Presentation on Outcomes : Ophthalmic Plastic & Reconstructive Surgery

Secondary Logo

Journal Logo

Original Investigations

Sebaceous Gland Carcinoma: Influence of Age at Presentation on Outcomes

Kaliki, Swathi M.D.*; Morawala, Ashi M.D.*; Krishnamurthy, Ajay M.D.*; Divya Jajapuram, Sai M.D.*; Mohamed, Ashik M.B.B.S., M.Tech., Ph.D.

Author Information
Ophthalmic Plastic and Reconstructive Surgery 37(4):p 341-345, July/August 2021. | DOI: 10.1097/IOP.0000000000001863


To assess the relationship between age at presentation and outcomes of patients with periocular sebaceous gland carcinoma.


Retrospective case series of 241 patients.


Of 241 cases, 29 (12%) were young adults (≤40 years), 122 (51%) were middle-aged adults (41–60 years), and 90 (37%) were older adults (>60 years). Based on the eighth edition of American Joint Committee on Cancer, most tumors belonged to T1 category (n = 78, 32%) on presentation. Wide excisional biopsy was the most common treatment modality (n = 183, 79%). There were no statistically significant differences in the clinical presentation, treatment approaches, and histopathology features amongst different age groups, except pagetoid spread which was higher in middle-aged adults (61%, p = 0.004). The incidence of tumor recurrence was higher in older age group compared to younger age groups, with 5-year, 10-year Kaplan-Meier estimate at 31%, 31% in young adults, 38%, 38% in middle-aged adults, and 45%, 100% in older adults (p = 0.03), respectively. The 10-year Kaplan-Meier estimate rate of locoregional lymph node metastasis, systemic metastasis, and death was higher in young adults (51%, 48%, and 48%, respectively) compared to middle-aged (30%, 17%, and 12%, respectively) and older adults (24%, 25%, and 27%, respectively), but the differences were not statistically significant.


There is no difference in the clinical presentation of periocular sebaceous gland carcinoma based on age. However, the tumor recurrence rate is much higher in the older age group and death higher in younger patients despite the same treatment strategies in all age groups.

© 2021 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.

You can read the full text of this article if you:

Access through Ovid